SG11201608123VA - Pharmaceutical composition for external use - Google Patents
Pharmaceutical composition for external useInfo
- Publication number
- SG11201608123VA SG11201608123VA SG11201608123VA SG11201608123VA SG11201608123VA SG 11201608123V A SG11201608123V A SG 11201608123VA SG 11201608123V A SG11201608123V A SG 11201608123VA SG 11201608123V A SG11201608123V A SG 11201608123VA SG 11201608123V A SG11201608123V A SG 11201608123VA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical composition
- external use
- external
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014070678A JP6580305B2 (en) | 2014-03-30 | 2014-03-30 | Pharmaceutical composition for external use |
PCT/JP2015/059323 WO2015151990A1 (en) | 2014-03-30 | 2015-03-26 | Pharmaceutical composition for external use |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201608123VA true SG11201608123VA (en) | 2016-11-29 |
Family
ID=54240316
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201810093PA SG10201810093PA (en) | 2014-03-30 | 2015-03-26 | Pharmaceutical composition for external use |
SG11201608123VA SG11201608123VA (en) | 2014-03-30 | 2015-03-26 | Pharmaceutical composition for external use |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201810093PA SG10201810093PA (en) | 2014-03-30 | 2015-03-26 | Pharmaceutical composition for external use |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP6580305B2 (en) |
CN (1) | CN106456598B (en) |
MY (1) | MY182059A (en) |
SG (2) | SG10201810093PA (en) |
TW (1) | TWI712408B (en) |
WO (1) | WO2015151990A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7086596B2 (en) * | 2017-12-28 | 2022-06-20 | 小林製薬株式会社 | External composition |
JP7086597B2 (en) * | 2017-12-28 | 2022-06-20 | 小林製薬株式会社 | External composition |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5976013A (en) * | 1982-10-23 | 1984-04-28 | Toko Yakuhin Kogyo Kk | Gelatinous pharmaceutical for surgical use |
JP3044352B2 (en) * | 1989-11-20 | 2000-05-22 | ライオン株式会社 | Patch |
CA2058975C (en) * | 1990-10-30 | 2000-06-06 | Shuichi Kasai | Antiinflammatory gel preparation |
JP3100408B2 (en) * | 1991-03-26 | 2000-10-16 | 株式会社資生堂 | Skin external preparation containing diclofenac sodium |
JPH11255644A (en) * | 1998-03-09 | 1999-09-21 | Lintec Corp | Percutaneous absorption type antipyretic antiphlogistic analgesic |
US7138394B2 (en) * | 2002-09-27 | 2006-11-21 | Alpharx Inc. | Vehicle for topical delivery of anti-inflammatory compounds |
JP4820065B2 (en) * | 2004-05-24 | 2011-11-24 | 同仁医薬化工株式会社 | Anti-inflammatory analgesic topical aqueous solution |
PE20060935A1 (en) * | 2004-10-21 | 2006-10-26 | Novartis Ag | PHARMACEUTICAL COMPOSITION INCLUDING DICLOFENACO |
CH699814B1 (en) * | 2007-05-14 | 2010-05-14 | Mepha Ag | Diclofenac for topical application as a spray. |
KR101517494B1 (en) * | 2007-06-08 | 2015-05-04 | 트로이카 파마슈티칼스 리미티드 | A novel non-aqueous topical solution of diclofenac and process for preparing the same |
MX2011008095A (en) * | 2009-01-30 | 2012-01-27 | Kydes Pharmaceuticals Llc | Transdermal delivery of diclofenac, carbamazepine and benzydamine. |
JP5421063B2 (en) * | 2009-10-23 | 2014-02-19 | 帝國製薬株式会社 | Diclofenac sodium-containing aqueous patch |
EP2753319B1 (en) * | 2011-09-09 | 2018-04-11 | Vizuri Health Sciences LLC | A pain relief composition, comprising a trpv1 selective agonist, and manufacture and uses thereof |
JP6738120B2 (en) * | 2013-03-29 | 2020-08-12 | 小林製薬株式会社 | External pharmaceutical composition |
-
2014
- 2014-03-30 JP JP2014070678A patent/JP6580305B2/en active Active
-
2015
- 2015-03-26 MY MYPI2016703598A patent/MY182059A/en unknown
- 2015-03-26 SG SG10201810093PA patent/SG10201810093PA/en unknown
- 2015-03-26 WO PCT/JP2015/059323 patent/WO2015151990A1/en active Application Filing
- 2015-03-26 TW TW104109752A patent/TWI712408B/en active
- 2015-03-26 CN CN201580028390.6A patent/CN106456598B/en active Active
- 2015-03-26 SG SG11201608123VA patent/SG11201608123VA/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2015151990A1 (en) | 2015-10-08 |
TWI712408B (en) | 2020-12-11 |
SG10201810093PA (en) | 2018-12-28 |
JP6580305B2 (en) | 2019-09-25 |
MY182059A (en) | 2021-01-18 |
JP2015189760A (en) | 2015-11-02 |
CN106456598B (en) | 2020-06-02 |
CN106456598A (en) | 2017-02-22 |
TW201622712A (en) | 2016-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1225655A1 (en) | Pharmaceutical compositions comprising azd9291 | |
GB201618482D0 (en) | Pharmaceutical compositions | |
GB201419257D0 (en) | Pharmaceutical compositions | |
GB201409471D0 (en) | Pharmaceutical composition | |
GB201402277D0 (en) | Pharmaceutical compounds | |
GB201404922D0 (en) | Pharmaceutical compounds | |
IL249553A0 (en) | Pharmaceutical compositions | |
SG11201605366QA (en) | Pharmaceutical composition containing pyridylaminoacetic acidcompound | |
GB201409488D0 (en) | Pharmaceutical composition | |
GB201409485D0 (en) | Pharmaceutical composition | |
ZA201702086B (en) | Long acting pharmaceutical compositions | |
GB201416513D0 (en) | Pharmaceutical compounds | |
ZA201502073B (en) | Pharmaceutical composition | |
IL250817A0 (en) | Pharmaceutical compositions | |
ZA201508726B (en) | Pharmaceutical composition | |
SG11201608123VA (en) | Pharmaceutical composition for external use | |
PT3200772T (en) | Pharmaceutical compositions comprising alpelisib | |
SI3089740T1 (en) | Pharmaceutical composition | |
SG11201608124XA (en) | Pharmaceutical composition for external use | |
SG10201504332VA (en) | Pharmaceutical Composition | |
SG11201608122PA (en) | Pharmaceutical composition for external use | |
SG2014014872A (en) | Pharmaceutical compositions | |
GB201408432D0 (en) | Pharmaceutical compositions | |
GB201404896D0 (en) | Pharmaceutical compounds | |
GB201402278D0 (en) | Pharmaceutical compounds |